EP Patent

EP3672960A2 — Compounds, salts thereof and their use for the treatment of diseases

Assigned to Acadia Pharmaceuticals Inc · Expires 2020-07-01 · 6y expired

What this patent protects

The present invention relates to compounds according to formulas (I), (II) and (VIII) useful for the treatment of diseases.

USPTO Abstract

The present invention relates to compounds according to formulas (I), (II) and (VIII) useful for the treatment of diseases.

Drugs covered by this patent

pimavanserin-tartrate (PIMAVANSERIN TARTRATE)

Patent Metadata

Patent number: EP3672960A2
Jurisdiction: EP
Classification: —
Expires: 2020-07-01
Drug substance claim: No
Drug product claim: No
Assignee: Acadia Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.